Stay updated on XmAb®20717 in Selected Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the XmAb®20717 in Selected Solid Tumors Clinical Trial page.

Latest updates to the XmAb®20717 in Selected Solid Tumors Clinical Trial page
- CheckyesterdayChange DetectedRemoved the general government funding/operating status notice from the page, which does not affect trial data or navigation. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.6%

- Check8 days agoNo Change Detected
- Check16 days agoChange DetectedThe history now shows updated entries for changes to the study status, recruitment details, and locations. These entries capture when and what changed.SummaryDifference0.1%

- Check44 days agoChange DetectedMajor update: page now includes a government funding status notice and indicates version 3.2.0, replacing the previous 3.1.0.SummaryDifference12%

- Check52 days agoChange DetectedUpdated the page revision from v3.0.2 to v3.1.0, indicating a new software release or document update. No changes to core content, pricing, or stock are evident.SummaryDifference0.3%

- Check66 days agoChange DetectedAdded revision: v3.0.2; removed previous revision: v3.0.1 and the 'Back to Top' element.SummaryDifference0.7%

- Check73 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes to core content or other important elements.SummaryDifference0.7%

Stay in the know with updates to XmAb®20717 in Selected Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the XmAb®20717 in Selected Solid Tumors Clinical Trial page.